Focus.
Samuel
Didier
D
Centre Hepatobiliaire, Hopital Paul Brousse, APHP, 12 Avenue Paul Vaillant Couturier, Inserm-Paris XI U 785, 94800 Villejuif, France. didier.samuel@pbr.aphp.fr
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D016503:Drug Delivery Systems; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D012254:Ribavirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D012254:Ribavirin; C026956:taribavirin